Imodium (Loperamide Hydrochloride)

Loperamide acts as a peripheral μ‑opioid receptor agonist in the gut. By binding to these receptors, it decreases smooth‑muscle activity in the intestinal wall, slows transit time, and promotes absorption of water and electrolytes. This combined effect reduces stool output and improves stool consistency.

The appropriate dose of Imodium is determined by a healthcare professional based on the patient’s age, weight, and severity of symptoms. The prescriber will set the exact regimen, and patients should follow the label or medical advice without altering the dose on their own.

Safety data for loperamide in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider after evaluating the individual situation.

To request Imodium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Imodium (loperamide) is a peripheral opioid agonist, whereas other over‑the‑counter options such as bismuth subsalicylate act by coating the gut and reducing inflammation. Loperamide generally provides faster reduction of stool frequency, but it must be used with caution in cases of infectious diarrhea where slowing motility could be harmful.

Imodium should be stored below 25 °C in a dry place. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure that the container is tightly closed to maintain stability throughout its shelf life.

Imodium is taken orally, usually as a tablet or chewable tablet. The tablet should be swallowed with a glass of water. If a chewable form is used, it should be chewed thoroughly before swallowing, following the dosage instructions provided by the prescriber or on the label.

The most serious risks include severe constipation leading to bowel obstruction, ileus, or toxic megacolon, especially if the drug is over‑used or taken in the presence of certain infections. Rarely, cardiac arrhythmias such as QT prolongation can occur, and allergic reactions may present as rash or swelling.

Imodium should be avoided in individuals with known hypersensitivity to loperamide, in children younger than two years, and in patients with acute dysentery, bacterial enterocolitis, or colitis caused by Clostridioides difficile unless directed by a physician. It is also contraindicated in patients with severe hepatic impairment.